References
- Kane J., Honigfeld G., Singer J., Meltzer H. Y., Clozaril Collaborative Study Group. Clozapine for the treatment resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–96
- Conley R. R., Schulz S. C., Baker R. W., Collins J. F., Bell J. A. Clozapine efficacy in schizophrenic nonre-sponders. Psychopharmacol Bull 1988; 24: 269–74
- Erlandsen C. Utpr0ving av et nytt neuroleptikum Leponex (clozapin) hos schizofrene med lang sykehistorie. Nord Psykiatr Tidsskr 1981; 35: 248–53
- Pickar D., Owen R. R., Litman R. E., Konicki E., Gutierrez R., Rapaport M. H. Clinical and biological response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch Gen Psychiatry 1992; 49: 345–53
- Tandon R., Goldman R., DeQuardo J. R., Goldman M., Perez M., Jibson M. Positive and negative symptoms covary during clozapine treatment in schizophrenia. J Psychiatr Res 1993; 27: 341–7
- Shopsin B., Klein H., Aaronson M., Collora M. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients. Arch Gen Psychiatry 1997; 36: 657–64
- Shopsin B., Klein H., Aronsen M. Clozapine: double-blind control trial in the treatment of acute schizophrenia. Psychopharmacol Bull 1978; 14: 12–5
- Ekblom B., Haggstrom J. E. Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties. Curr Ther Res 1974; 16: 945–57
- Ratey J. J., Leveroni C., Kilmer D., Gutheil C., Swartz B. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry 1993; 54: 219–23
- Leadbetter R. A., Spears N., Shutty M. S. Influence of clozapine on polydipsia and hyponatremia. American Psychiatric Association, 146th Annual Meeting. 1993 new research, program and abstracts. 1993, 130
- Goldberg T. E., Greenberg D., Griffin S. J., Gold J. M., Kleinman J. E., Pickar D. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993; 162: 43–8
- Safferman A. Z., Lieberman J. A., Pollack S., Szymanski S., Masiar S., Johns C. Predictors of response to clozapine in chronic schizophrenia. Biol Psychiatry 1993; 33 Suppl 6A: 131A
- Owen R. R., Beake B. J., Marby D., Dessain E. C., Cole J. O. Response to clozapine in chronic psychotic patients. Psychopharmacoll Bull 1989; 25: 253–6
- Jewart R. D., Lewine RRJ, Manning D. E., Risby E. D., Risch S. C. Brain MRJ abnormalities associated with reduced antipsychotic response to clozapine in schizophrenic patients. Biol Psychiatry 1991; 29 Suppl 9A: 43A
- Kay S. R. Positive and negative syndromes in schizophrenia: Assessment and research. Brunner/Mazel, New York 1991
- Honigfeld G., Gillis R. D., Klett C. J. Nurses' Observation Scale for Inpatient Evaluation. ECDEU, Washington 1967; 265–73
- Lingjærde O, Ahlfors U. G., Bech P., Dencker S. J., Elgen K. The UKU side effect rating scale. Acta Psychiatr Scand 1987; 76 Suppl 334
- Meltzer H. Y. The effect of clozapine and other atypical antipsychotic drugs on negative symptoms. Negative versus positive schizophrenia, A. Mameros, N. C. Andreasen, M. T. Tsuang. Springer Verlag, Berlin 1991; 365–76
- Claghorn J., Honigfeld G., Abuzzahab F. S., Wang R., Steinbook R., Tuason V. The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 1987; 7: 377–84
- Carpenter W. T., Heinrichs D. W., Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988; 145: 578–83
- Lindenmayer J-P, Grochowski S., Mabugat L. Clozapine effects on positive and negative symptoms: A six-month trial of treatment-refractory schizophrenics. J Clin Psychopharmacol 1994; 14: 201–4